Source: Pharmacy Times articles
A new study reveals that heart failure patients with implantable devices are more likely to receive the pneumococcal conjugate vaccine 13, impacting vaccination rates and mortality.
Read More
by MM360 Staff | May 16, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
A new study reveals that heart failure patients with implantable devices are more likely to receive the pneumococcal conjugate vaccine 13, impacting vaccination rates and mortality.
Read More